Intravenous or Hepatic Arterial Infusion of Fotemustine in Treating Patients With Unresectable Liver Metastases From Eye Melanoma

NCT00110123 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

171

Enrollment

NETWORK

Sponsor class

Stopped low accrual

Conditions

Intraocular Melanoma
Metastatic Cancer

Interventions

DRUG: fotemustine
DRUG: isolated perfusion

Sponsor

European Organisation for Research and Treatment of Cancer - EORTC